DiscoverStartupsRemedy Plan TherapeuticsRemedy Plan Therapeutics Funding Rounds, Valuation & Investors
Remedy Plan is developing the first drugs that halt tumor growth and disrupt metastasis 1-10 Employees
- Early StageStartup in initial stages
Remedy Plan Therapeutics Funding
Remedy Plan Therapeutics is active in the following markets / industries: biotechnology, medical, breast cancer and Drug development. The company has secured funding across 5 rounds and is valued at $0. Their most recent funding was raised on September 30, 2019.
Funding Rounds
A
$5300000S
$1500000S
$2100000S
$1200000U
$102925Investors of Remedy Plan Therapeutics
Schooner Capital
Crowdfunding
Rounds
U